Low baseline levels of cerebrospinal fluid biomarker amyloid beta 1-42 (CSF Aß1-42) and p-tau and decreased Aß1-42:tau ratios may be predictors of cognitive decline in PD [144]. This evidence concerns the gene MAPT and Parkinson disease.